Hjem › Perifer arteriesygdom › Tennessee
Perifer arteriesygdom kliniske forsøg i Tennessee
14 studier for Perifer arteriesygdom søger deltagere på steder i Tennessee.
Byer i Tennessee
Officiel studietekst (engelsk)
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Apex Research Foundation, LLC, Jackson
- Tennova TCMC, Knoxville
- Vanderbilt Heart and Vascular Tullahoma, Cardiology and Vascular Associates, Tullahoma
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07318610Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- The Jackson Clinic, Jackson
- East Coast Institute for Research - Jefferson City, Jefferson City
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07223593Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Southeast Renal Research Institute, Chattanooga
- Dialysis Clinic Inc - University Nephology, Knoxville
- Knoxville Kidney Center PLLC, Knoxville
- og 2 flere
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- Tennessee Center for Clinical Trials, Tullahoma
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 27. aug. 2026 · NCT06321575The THOR IDE Study
- Vascular Institute of Chattanooga, Chattanooga
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 11. jun. 2026 · NCT05916950The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
- Wellmont Holston Valley Medical Center, Kingsport
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 13. maj 2026 · NCT05811364REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center
- University of Tennessee Medical Center, Knoxville
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 29. apr. 2026 · NCT07223437SELUTION4BTK Trial
- Vanderbilt University Medical Center, Nashville
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 28. apr. 2026 · NCT05055297PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
- Vanderbilt University Medical Center, Nashville
Rekrutterer
Alder 18 til 95 · Alle køn · Opdateret 16. apr. 2026 · NCT05313165Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Vanderbilt University Medical Center, Nashville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. mar. 2026 · NCT04774159Randomized Clinical Trial for Ewing Amputation in the VA
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Rekrutterer
Alle aldre · Alle køn · Opdateret 9. feb. 2026 · NCT05437562Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
- Wellmont CVA Heart Institute, Kingsport
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. feb. 2026 · NCT01904851Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Memphis VA Medical Center, Memphis, TN, Memphis
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 17. dec. 2025 · NCT02915198Pounce™ Thrombectomy System Retrospective Registry
- Vanderbilt University Medical Center, Nashville
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2025 · NCT05868161Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.